30 days FREE from Class 9 to DropperRegister free

The first clinical gene therapy was given in 1990 to a 4-year-old girl suffering from ADA deficiency. Which of the following statements about this therapy is INCORRECT?

BiologyBiotechnology and its Applications · Gene Therapy
  • A. ADA (Adenosine Deaminase) deficiency is caused by deletion of the gene for ADA enzyme
  • B. Lymphocytes from the patient's blood were grown in culture and a functional ADA gene was introduced using a retroviral vector
  • C. The genetically engineered lymphocytes were returned to the patient and provided a permanent cure for the disease
  • D. ADA deficiency leads to compromised immune function
Show answer & explanation

Answer: (C) The genetically engineered lymphocytes were returned to the patient and provided a permanent cure for the disease

Explanation

The gene therapy for ADA deficiency was NOT a permanent cure. The introduced lymphocytes had a limited lifespan in the body. Since the cells were not introduced into the bone marrow stem cells, the patient required periodic infusions of genetically engineered lymphocytes. A permanent cure would require introduction of the functional gene into early embryonic cells or bone marrow stem cells. All other statements are correct.

Practise every Biotechnology and its Applications question with a timer

Chapter tests, full NEET mocks, your score and weak topics — 70,000+ questions on YNeet.

Start free for 30 days

No payment, no card. Sign up in 30 seconds.

For Class 11, 12 and droppers, see what the YNeet NEET online course includes.

More Biotechnology and its Applications questions

All free Biotechnology and its Applications PYQs →